Doohyun Lee

Title: Doohyun Lee: Innovator in Pharmaceutical Composition

Introduction

Doohyun Lee is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address vascular inflammation-related infectious diseases.

Latest Patents

Doohyun Lee holds a patent for "2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivatives and use thereof." This patent describes a pharmaceutical composition that includes a 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivative as an active ingredient. The composition is effective against vascular inflammation-related infectious diseases triggered by the activity of the HMGB1 protein. His research indicates that this pharmaceutical composition can increase the survival rate in sepsis animal tests, making it a potential therapeutic agent for vascular inflammatory diseases and infections, including sepsis.

Career Highlights

Throughout his career, Doohyun Lee has been associated with prominent institutions such as the Kyungpook National University Industry-Academic Cooperation Foundation and the Daegu-Gyeongbuk Medical Innovation Foundation. His work in these organizations has allowed him to advance his research and contribute to the medical field significantly.

Collaborations

Doohyun Lee has collaborated with notable colleagues, including Taeho Lee and Jong-Sup Bae. These partnerships have fostered innovation and development in his research endeavors.

Conclusion

Doohyun Lee's contributions to pharmaceutical innovation, particularly through his patented work, highlight his role as a key figure in addressing critical health issues. His ongoing research and collaborations continue to pave the way for advancements in medical treatments.